David D. Kershenobich-Stalnikowitz

Mexico, MEX 14080, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Title Not Found

Title Not Found

Journal: Salud publica de Mexico
Published: August 07, 2025

Granulomatous liver disease in a referral center in Mexico city.

Granulomatous liver disease in a referral center in Mexico city.

Journal: Annals of hepatology
Published: February 28, 2025

Title Not Found

Title Not Found

Journal: Salud publica de Mexico
Published: June 17, 2024

Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study.

Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study.

Journal: Therapeutic advances in infectious disease
Published: November 07, 2023

Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.

Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: June 27, 2023

Burden of disease due to liver cirrhosis in Mexico.

Burden of disease due to liver cirrhosis in Mexico.

Journal: Gaceta medica de Mexico
Published: January 01, 2023

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.

Journal: Open forum infectious diseases
Published: July 02, 2022

Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.

Correction: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.

Journal: PloS one
Published: May 23, 2022

Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.

Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.

Journal: Clinical liver disease
Published: March 21, 2022

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis.

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis.

Journal: Gastroenterologia y hepatologia
Published: January 17, 2022

Territorial Strategy of Medical Units for Addressing the First Wave of the COVID-19 Pandemic in the Metropolitan Area of Mexico City: Analysis of Mobility, Accessibility and Marginalization.

Territorial Strategy of Medical Units for Addressing the First Wave of the COVID-19 Pandemic in the Metropolitan Area of Mexico City: Analysis of Mobility, Accessibility and Marginalization.

Journal: International journal of environmental research and public health
Published: October 30, 2021

THE NATIONAL INSTITUTE OF MEDICAL SCIENCES AND NUTRITION SALVADOR ZUBIRáN: A BRIEF JOURNEY THROUGH ITS HISTORY.

THE NATIONAL INSTITUTE OF MEDICAL SCIENCES AND NUTRITION SALVADOR ZUBIRáN: A BRIEF JOURNEY THROUGH ITS HISTORY.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
Published: October 05, 2021
Showing 1-12 of 39

Last Updated: 09/26/2026